Click to cancel search
Login
Sign Up
Home Page
How It Works
Our Story
Symptom Checker
Second Opinion Finder
Newsroom
Partner With Us
MediFind Pro
FAQ
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
Submit Feedback
Advertising Policy
Privacy Policy
Terms & Conditions
Condition
Condition
Doctor
Symptom
Condition
Click to search for condition or expert
Login
Sign Up
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Smith-Magenis Syndrome
Overview
Condition 101
Find a Doctor
Latest Research
Clinical Trials
Latest Research
Latest Advance
Study
Condition:
Sleep in Children with Autism Spectrum Disorder
Journal:
Journal of autism and developmental disorders
Treatment Used:
Pediatric Prolonged-Release Melatonin
Number of Patients:
125
Published —
May 13, 2019
This study evaluated the effectiveness and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2-5 mg) in improving sleep duration and onset in children aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia.
Latest Advance
Study
Condition:
Self-injurious Behaviors in Children with Neurodevelopmental Disorders (NDDs)
Journal:
Pharmacotherapy
Treatment Used:
Behavior Therapies and Pharmocotherapy
Number of Patients:
0
Published —
February 23, 2019
This article discusses the management of self-injurious behaviors in children with neurodevelopmental (NDDs) disorders.
Latest Advance
Study
Condition:
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Journal:
Blood
Treatment Used:
Duvelisib vs, Ofatumumab
Number of Patients:
319
Published —
October 06, 2018
This study compared duvelisib versus ofatumumab monotherapy for patients with relapsed or refractory (RR) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Latest Advance
Study
Condition:
Relapsed/refractory deletion 17p chronic lymphocytic leukaemia
Journal:
British journal of haematology
Treatment Used:
Ibrutinib
Number of Patients:
230
Published —
June 07, 2018
This study evaluated the clinical outcomes of patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia (CLL/SLL) from three studies which included Ibrutinib.
